Hepatic impairment No dose adjustment is required for patients with hepatic impairment. Practical experience with the use of tirzepatide in individuals with critical hepatic impairment is proscribed. Warning should be exercised when managing these clients with tirzepatide (see part 5.2). Remain up-to-date on the most recent products releases, Specific offers https://annet753sdn4.tokka-blog.com/profile